
Vesicor Therapeutics and Black Hawk Acquisition Corporation Announce Closing
SAN GABRIEL, Calif., Nov. 20, 2026 (GLOBE NEWSWIRE) -- Vesicor Therapeutics Holdings, Inc. (“Vesicor” or the “Company”), an early development stage biotechnology company focused on the development of p53-based…
Read report ↗





